High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: Insights from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial
- Hijazi, Ziad M.
- Siegbahn, Agneta
- Andersson, Ulrika
- Granger, Christopher B.
- Alexander, John H.
- Atar, Dan
- Gersh, Bernard J.
- Mohan, Puneet
- Harjola, Veli-Pekka
- Horowitz, John
- Husted, Steen
- Hylek, Elaine
- Lopes, Renato D.
- McMurray, John
- Wallentin, Lars
Publication date
January 2014
DOI Publisher
Ovid Technologies (Wolters Kluwer Health)Abstract
High-sensitivity troponin-I (hs-TnI) measurement improves risk assessment for cardiovascular events in many clinical settings, but the added value in atrial fibrillation patients has not been described
Add to ORKG